Tilray Inc (NASDAQ:TLRY - Get Free Report) shares traded down 2.2% during trading on Tuesday . The company traded as low as $0.91 and last traded at $0.91. 16,618,676 shares changed hands during trading, a decline of 64% from the average session volume of 46,338,965 shares. The stock had previously closed at $0.93.
Wall Street Analyst Weigh In
Separately, Canaccord Genuity Group upped their price objective on Tilray from $2.00 to $3.00 and gave the stock a "buy" rating in a research note on Monday, January 13th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $2.70.
Get Our Latest Report on TLRY
Tilray Stock Performance
The company has a market cap of $892.18 million, a P/E ratio of -3.17 and a beta of 2.07. The company has a 50 day moving average price of $1.17 and a 200-day moving average price of $1.47. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10.
Tilray (NASDAQ:TLRY - Get Free Report) last released its quarterly earnings results on Friday, January 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.07). Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The business had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. Tilray's revenue for the quarter was up 8.7% compared to the same quarter last year. Equities analysts expect that Tilray Inc will post -0.2 EPS for the current fiscal year.
Institutional Trading of Tilray
Institutional investors have recently modified their holdings of the company. Ferguson Wellman Capital Management Inc. acquired a new stake in shares of Tilray in the third quarter valued at $26,000. Lido Advisors LLC acquired a new stake in shares of Tilray in the fourth quarter valued at $28,000. Dudley Capital Management LLC acquired a new stake in shares of Tilray in the fourth quarter valued at $29,000. Verdence Capital Advisors LLC acquired a new stake in shares of Tilray in the fourth quarter valued at $29,000. Finally, International Assets Investment Management LLC lifted its holdings in shares of Tilray by 335.3% in the third quarter. International Assets Investment Management LLC now owns 23,639 shares of the company's stock valued at $42,000 after buying an additional 18,208 shares during the period. Institutional investors and hedge funds own 9.35% of the company's stock.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Recommended Stories
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
